Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Protirelin (substance) |
Is a |
False |
Thyrotropin releasing factor agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing thyrotrophin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Thyrotropin releasing factor agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing thyrotropin releasing factor (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Thyrotropin releasing factor agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing thyrotropin alfa (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Thyrotropin releasing factor agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Thyrotropin alfa 1.1mg/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Thyrotropin releasing factor agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Thyrotropin alfa 0.9mg/mL powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Thyrotropin releasing factor agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to thyrotrophin (finding) |
Causative agent (attribute) |
False |
Thyrotropin releasing factor agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Thyrotropin alfa (substance) |
Is a |
False |
Thyrotropin releasing factor agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to thyrotrophin (finding) |
Causative agent (attribute) |
False |
Thyrotropin releasing factor agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Protirelin allergy |
Causative agent (attribute) |
False |
Thyrotropin releasing factor agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |